Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial

Ashley S. Felix, D. Scott McMeekin, David Mutch, Joan L. Walker, William T. Creasman, David E. Cohn, Shamshad Ali, Richard G. Moore, Levi S. Downs, Olga B. Ioffe, Kay J. Park, Mark E. Sherman, Louise A. Brinton

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

Background Few studies have analyzed relationships between risk factors for endometrial cancer, especially with regard to aggressive (non-endometrioid) histologic subtypes, and prognosis. We examined these relationships in the prospective NRG Oncology/Gynecologic Oncology Group 210 trial. Methods Prior to surgery, participants completed a questionnaire assessing risk factors for gynecologic cancers. Pathology data were derived from clinical reports and central review. We used the Fine and Gray subdistribution hazards model to estimate subhazard ratios (HRs) and 95% confidence intervals (CIs) for associations between etiologic factors and cause-specific subhazards in the presence of competing risks. These models were stratified by tumor subtype and adjusted for stage and socioeconomic status indicators. Results Median follow-up was 60 months after enrollment (range: 1 day-118 months). Among 4609 participants, a total of 854 deaths occurred, of which, 582 deaths were attributed to endometrial carcinoma. Among low-grade endometrioid cases, endometrial carcinoma-specific subhazards were significantly associated with age at diagnosis (HR = 1.04, 95% CI = 1.01-1.06 per year, P-trend) and BMI (class II obesity vs. normal BMI: HR = 2.29, 95% CI = 1.06-4.98, P-trend = 0.01). Among high-grade endometrioid cases, endometrial carcinoma-specific subhazards were associated with age at diagnosis (HR = 1.05, 95% CI = 1.02-1.07 per year, P-trend < 0.001). Among non-endometrioid cases, endometrial carcinoma-specific subhazards were associated with parity relative to nulliparity among serous (HR = 0.55, 95% CI = 0.36-0.82) and carcinosarcoma cases (HR = 2.01, 95% CI = 1.00-4.05). Discussion Several endometrial carcinoma risk factors are associated with prognosis, which occurs in a tumor-subtype specific context. If confirmed, these results would suggest that factors beyond histopathologic features and stage are related to prognosis. ClinicalTrials.gov Identifier: NCT00340808.

Original languageEnglish (US)
Pages (from-to)70-76
Number of pages7
JournalGynecologic oncology
Volume139
Issue number1
DOIs
StatePublished - Oct 2015

Bibliographical note

Funding Information:
This study was supported by National Cancer Institute grants to the Gynecologic Oncology Group Administrative Office ( CA 27469 ), the Gynecologic Oncology Group Statistical and Data Center ( CA 37517 ) and the NRG Oncology Grant number: U10 CA180822 . In addition, this research was supported in part by funds provided by the intramural research program of the National Cancer Institute , National Institutes of Health.

Keywords

  • Endometrial cancer
  • Etiologic factors
  • GOG
  • NRG
  • Prognosis

Fingerprint Dive into the research topics of 'Associations between etiologic factors and mortality after endometrial cancer diagnosis: The NRG Oncology/Gynecologic Oncology Group 210 trial'. Together they form a unique fingerprint.

Cite this